Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Alan S. Coates
Based on 58 articles published since 2009
(Why 58 articles?)
||||
Expertise Level
The expertise of Alan S. Coates ranks in the
  • Top 0.2%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 58 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Coates, A S   ·   Coates, A   ·   Coates, Angela   ·   Coates, Alan S   ·   Coates, Alan
Work Locations
Details
Most likely:    University of Sydney      
2018
  • Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: · IBCSG Statistical Center and Department of Mathematics and Statistics, University of Vermont, Burlington, VT, USA. · International Breast Cancer Study Group (IBCSG) Central Pathology Office, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. · Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. · Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Central Pathology Office, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy. · Centro di Riferimento Oncologico, Aviano, Italy. · Department of Surgical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Orsola Hospital and University of Bologna, Bologna, Italy. · Riverina Cancer Care Centre, Wagga Wagga, NSW, Australia. · Breast Center St Gallen, Kantonsspital, St Gallen, Switzerland. · Department of Medical Oncology, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · IBCSG and University of Sydney, Sydney, NSW, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · IBCSG and European Institute of Oncology, Milan, Italy. · Pubmed 30196031
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, and Harvard T.H Chan School of Public Health, Boston, MA, USA. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, Department of Oncology and Hemato-oncology, European Institute of Oncology and University of Milan, Milan, Italy. · National Institute of Oncology, Budapest, Hungary. · Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Rimini, Dipartimento di Oncologia ed Ematologia, AUSL della Romagna, Rimini, Italy. · Translational Research Coordination and Central Pathology Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan and International Breast Cancer Study Group Central Pathology Office, Milan, Italy. · Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, and International Breast Cancer Study Group, Prato, Italy. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School and Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Scientific & Clinical Evaluation Board, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, and International Breast Cancer Study Group, Milan, Italy. · Pubmed 29589138
  • International Breast Cancer Study Group, Milan, Italy; Division of Medical Senology, Milan, Italy. Electronic address: · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA. · International Breast Cancer Study Group and Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · International Breast Cancer Study Group, Australia and New Zealand Breast Cancer Trials Group, and Box Hill and Maroondah Hospitals, Monash University, Melbourne, VIC, Australia. · International Breast Cancer Study Group and Lucerne Canton Hospital, Lucerne, Switzerland. · International Breast Cancer Study Group, Centre Hospitalier Universitaire de Liège, Liège University, Liège, Belgium. · International Breast Cancer Study Group and Multidisciplinary Breast Center, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium. · International Breast Cancer Study Group and National Institute of Oncology, Budapest, Hungary. · International Breast Cancer Study Group and Centre Hospitalier Chrétien Clinique St Joseph, Liège, Belgium. · International Breast Cancer Study Group and ASST Spedali Civili di Brescia, Brescia, Italy. · Danish Breast Cancer Group and Rigshospitalet, Copenhagen, Denmark. · Scottish Cancer Trials Breast Group and The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · German Breast Group, Neu-Isenburg, Germany. · SOLTI Group and Fundación Instituto Valenciano de Oncologia, Valencia, Spain. · Japan Breast Cancer Research Group and Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. · Austrian Breast & Colorectal Cancer Study Group and Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria. · Chilean Cooperative Group for Oncologic Research, Providencia, Santiago, Chile. · Cancer Trials Ireland and Cork University Hospital, Cork, Ireland. · International Breast Cancer Study Group and Centro di Riferimento Oncologico di Aviano, Aviano, Italy. · Medical Oncology Clinic, Institute Jules Bordet, Brussels, Belgium. · Swiss Group for Clinical Cancer Research, International Breast Cancer Study Group, and Breast Center St Gallen, St Gallen, Switzerland. · Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Central Pathology Office and University of Milan, Milan, Italy. · International Breast Cancer Study Group, Inselspital, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia. · International Breast Cancer Study Group and Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group, Milan, Italy; European Institute of Oncology, Milan, Italy. · Pubmed 29158011
  • Irene L. Wapnir, Stanford University School of Medicine, Stanford, CA · Karen N. Price and Shari Gelber, Frontier Science and Technology Research Foundation, Richard D. Gelber, Frontier Science and Technology Research Foundation, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, Meredith M. Regan, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · Stewart J. Anderson, University of Pittsburgh Graduate School of Public Health · Priya Rastogi, University of Pittsburgh Cancer Institute · Norman Wolmark, Allegheny Health Network Cancer Institute, Pittsburgh, PA · André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec · Alexander H.G. Paterson, Tom Baker Cancer Centre, Calgary, Alberta, Canada · Miguel Martín, CIBERONC, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Madrid · José Manuel Baena-Cañada, Hospital Puerta del Mar, Cádiz, Spain · Johan W.R. Nortier, Leids Universitair Medisch Centrum, Leiden, Netherlands · Mothaffar F. Rimawi, Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX · István Láng, National Institute of Oncology, Budapest, Hungary · Beat Thürlimann, Kantonsspital, St. Gallen · Stefan Aebi, Lucerne Cantonal Hospital and University of Bern, Switzerland · Eleftherios P. Mamounas, Orlando Health University of Florida Health Cancer Center, Orlando, FL · Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA · and Alan S. Coates, University of Sydney, Sydney, Australia. · Pubmed 29443653
  • National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Locked Bag 7, Camperdown, NSW, 1450, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · International Breast Cancer Study Group and Inselspital, Bern University Hospital, Bern, Switzerland. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Locked Bag 7, Camperdown, NSW, 1450, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 29329582
  • International Breast Cancer Study Group (IBCSG) Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · International Breast Cancer Study Group, Data Management Center, Amherst, NY, USA. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center and Bern University Hospital, Inselspital, Bern, Switzerland. · Pubmed 28875248
2017
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston. · International Breast Cancer Study Group Statistical Center, Boston, USA. · University of Calgary and Canadian Cancer Trials Group, Calgary, Canada. · Division of Cancer Medicine, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne. · Australia & New Zealand Breast Cancer Trials Group and International Breast Cancer Study Group, Melbourne, Australia. · The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, USA. · National Institute of Oncology and International Breast Cancer Study Group, Medical Oncology, Budapest, Hungary. · Division of Medicine, Instituto Nacional de Enfermedades Neoplásicas and International Breast Cancer Study Group, Lima, Peru. · Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan. · Medical Oncology, Ospedale Papa Giovanni XXIII and International Breast Cancer Study Group, Bergamo. · Medical Oncology, ASST Sette Laghi-Ospedale di Circolo and Fondazione Macchi and International Breast Cancer Study Group, Varese, Italy. · Allan Blair Cancer Center, Regina, Canada. · Medical Oncology, Centro di Riferimento Oncologico and International Breast Cancer Study Group, Aviano, Italy. · Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre and International Breast Cancer Study Group, Mumbai, India. · Breast Center St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen. · International Breast Cancer Study Group, St. Gallen, Switzerland. · Australia & New Zealand Breast Cancer Trials Group and International Breast Cancer Study Group, The Tweed Hospital, Griffith University Gold Coast, Tweed Heads, Australia. · Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, Boston, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Oncology Institute of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bellinzona. · International Breast Cancer Study Group, Lugano, Viganello, Switzerland. · Pubmed 28911092
  • Signe Borgquist and Judy E. Garber, Dana-Farber Cancer Institute, Harvard Medical School · Anita Giobbie-Hurder, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute · Richard D. Gelber, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, T.H. Chan Harvard School of Public Health, and Frontier Science and Technology Research Foundation · Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation · Meredith M. Regan, IBCSG Statistical Center, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA · Signe Borgquist, Lund University, Lund, Sweden · Thomas P. Ahern, University of Vermont, Burlington, VT · Marco Colleoni and Aron Goldhirsch, IBCSG and European Institute of Oncology, Milan, Italy · István Láng, IBCSG and National Institute of Oncology, Budapest, Hungary · Marc Debled, Institut Bergonié, Bordeaux, France · Bent Ejlertsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark · Roger von Moos, Cantonal Hospital Graubuenden, Chur · Swiss Group for Clinical Cancer Research and IBCSG · Manuela Rabaglio, IBCSG Coordinating Center and Inselspital, Bern · Beat Thürlimann, Breast Center St. Gallen, Kantonsspital, St. Gallen · Swiss Group for Clinical Cancer Research and IBCSG, Bern, Switzerland · Ian Smith, The Royal Marsden Hospital, London, United Kingdom · and Alan S. Coates, IBCSG and University of Sydney School of Public Health, Sydney, Australia. · Pubmed 28380313
  • Poornima Saha and Gini F. Fleming, The University of Chicago Medical Center, Chicago, IL · Meredith M. Regan, Weixiu Luo, Harold J. Burstein, and Richard D. Gelber, Dana-Farber Cancer Institute · Meredith M. Regan, Harold J. Burstein, and Richard D. Gelber, Harvard Medical School · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA · Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello · Karin Ribi and Jürg Bernhard, International Breast Cancer Study Group Coordinating Center · Jürg Bernhard, Bern University Hospital, Inselspital, Bern, Switzerland · Prudence A. Francis, Peter MacCallum Cancer Center · St Vincent's Hospital · University of Melbourne, Melbourne · Josephine Stewart, Austin and Heidelberg Repatriation Medical Center, Heidelberg, Victoria · Prudence A. Francis, Josephine Stewart, and Michelle Nottage, University of Newcastle, Newcastle · Alan S. Coates, University of Sydney, Sydney, New South Wales · Michelle Nottage, Royal Brisbane Hospital, Brisbane, Queensland, Australia · Barbara A. Walley, University of Calgary · National Cancer Institute of Canada, Calgary, Alberta, Canada · Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru · Vani Parmar, Tata Memorial Centre, Mumbai, India · Roberto Torres, Instituto Nacional del Cancer, Santiago de Chile, Chile · Meritxell Bellet, Vall d'Hebron Institute of Oncology · Vall d'Hebron University Hospital · Universitat Autònoma de Barcelona, Barcelona · Antonia Perelló, Hospital Universitari Son Espases, Palma de Mallorca, Spain · Faysal Dane, Marmara University Hospital, Istanbul, Turkey · Antonio Moreira, Instituto Português de Oncologia Francisco Gentil - Centro de Lisboa, Lisbon, Portugal · Daniel Vorobiof, Sandton Oncology Centre, Johannesburg, South Africa · and Aron Goldhirsch and Marco Colleoni, European Institute of Oncology, Milan, Italy. · Pubmed 28654365
  • James P. Morden, Lucy Kilburn, Claire Snowdon, and Judith M. Bliss, The Institute of Cancer Research · Hanna Nicholas, Cancer Research UK · R. Charles Coombes, Imperial College London, London · Gianfilippo Bertelli, Singleton Hospital, Swansea · Robert Coleman, Weston Park Hospital, Sheffield · Lesley Fallowfield, University of Sussex, Brighton · David Dodwell, St James Hospital, Leeds, United Kingdom · Isabel Alvarez, Hospital Donostia, GEICAM Spanish Breast Cancer Group, San Sebastian, Spain · Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia · Jacek Jassem, Medical University of Gdansk, Gdansk, Poland · Stephen Jones, US Oncology Research, The Woodlands, TX · Per E. Lønning, University of Bergen and Haukeland University Hospital, Bergen, Norway · Olaf Ortmann, University Medical Center Regensburg, Regensburg, Germany · Cornelis van de Velde, Leiden University Medical Centre, Leiden, the Netherlands · Jørn Andersen, Aarhus University Hospital, Aarhus, Denmark · Lucia Del Mastro, IRCCS Azienda Ospedaliera Universitaria San Martino IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy · Stig Holmberg, Sahlgrenska Universitetssjukhuset, Goteborg, Sweden · and Robert Paridaens, Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium. · Pubmed 28467729
  • NRG Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. · NRG Oncology and University of Florida Health Cancer Center at Orlando Health, Orlando, FL, USA. · NRG Oncology and Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada. · GEICAM, Instituto de Investigacion SanitariaGregorio Marañon, Universidad Complutense, Madrid, Spain. · BOOG, Dutch Breast Cancer Trialists' Group, Leids Universitair Medisch Centrum, Leiden, Netherlands. · NRG Oncology and Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · NRG Oncology and Tom Baker Cancer Centre, Calgary, Alberta, Canada. · IBCSG and National Institute of Oncology, Budapest, Hungary. · IBCSG, Bern, Switzerland and University of Sydney, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · NRG Oncology and the Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · IBCSG, Luzerner Kantonsspital, Lucerne and University of Berne, Switzerland and Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Pubmed 27663567
2016
  • Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology · Giuseppe Viale, University of Milan, Milan · Lorenzo Gianni, Ospedale degli Infermi, Rimini · Fabio Puglisi, University Hospital of Udine, University of Udine, Udine · Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo · Katia Cagossi, Ospedale di Carpi, Carpi, Italy · Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center · Kathryn P. Gray, Shari Gelber, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute · Kathryn P. Gray and Richard D. Gelber, Harvard T.H. Chan School of Public Health · Richard D. Gelber and Meredith M. Regan, Harvard Medical School · Richard D. Gelber and Karen N. Price, Frontier Science and Technology Foundation, Boston, MA · István Láng, National Institute of Oncology, Budapest, Hungary · Beat Thürlimann, Kantonsspital, St Gallen · Beat Thürlimann, Elena Kralidis, and Daniel Rauch, Swiss Group for Clinical Cancer Research, Bern · Elena Kralidis, Kantonsspital Aarau, Aarau · Daniel Rauch, Spital Thun, Thun, Switzerland · Ehtesham A. Abdi, The Tweed Head Hospital, Tweed Heads, New South Wales and Griffith University, Southport, Queensland · Ehtesham A. Abdi and Jacquie Chirgwin, Australia and New Zealand Breast Cancer Trials Group · Jacquie Chirgwin, Box Hill and Maroondah Hospitals and Monash University, Melbourne, Victoria · Alan S. Coates, International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, New South Wales, Australia · Henry L. Gomez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru · Barbro K. Linderholm, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden · and Alexandru Eniu, Cancer Institute Ion Chiricuta, Cluj, Romania. · Pubmed 27325862
  • Jacquie H. Chirgwin and John F. Forbes, University of Newcastle · John F. Forbes, Calvary Mater Newcastle, Newcastle · Alan S. Coates, University of Sydney School of Public Health, Sydney, New South Wales · Jacquie H. Chirgwin, Box Hill Hospital · Jacquie H. Chirgwin, Maroondah Hospital · Jacquie H. Chirgwin, Monash University, Melbourne, Victoria, Australia · Anita Giobbie-Hurder, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard Medical School, Boston, MA · Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark · Marc Debled, Institut Bergonié, Bordeaux, France · Aron Goldhirsch and Marco Colleoni, European Institute of Oncology, Milan, Italy · Ian Smith, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom · Manuela Rabaglio, Inselspital, Bern · Beat Thürlimann, Kantonsspital, St. Gallen, Switzerland · Patrick Neven, University of Leuven · Patrick Neven, University Hospitals Leuven, Leuven, Belgium · István Láng, National Institute of Oncology, Budapest, Hungary. · Pubmed 27217455
  • Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia · Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia. · Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia Patricia Ritchie Centre for Cancer Care and Research, North Sydney. · Ballarat Oncology and Haematology, Wendouree. · Department of Surgery, Royal Adelaide Hospital, Adelaide. · Department of Medical Oncology, Royal Perth Hospital, Perth. · School of Surgery, University of Western Australia, Crawley. · Southern Highlands Cancer Centre, Bowral. · Department of Surgery, St John of God Hospital, Bunbury, Australia. · Breast Care Centre, Waikato Hospital, Hamilton, New Zealand. · Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville. · Australia and New Zealand Breast Cancer Trials Group, Waratah National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Australia. · Australia and New Zealand Breast Cancer Trials Group, Waratah. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Pubmed 26861603
  • Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Avenue, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Swiss Group for Clinical Cancer Research SAKK, Lugano Viganello, Switzerland. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Via Ripamonti 435, Milan, 20141, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · IBCSG Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · Dana-Farber Cancer Institute, Department of Biostatistics and Computatonal Biology, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, 450 Brookline Avenue, Boston, MA, 02215, USA. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · National Cancer Institute of Canada, Kingston, ON, Canada. · Pubmed 27825388
  • Department of Oncology, Institute of Clinical Sciences, Sahgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: · Department of Mathematics and Statistics, University of Vermont, Burlington, Vermont. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, Massachusetts. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Frontier Science and Technology Research Foundation, Harvard T. F. Chan School of Public Health, Boston, Massachusetts. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · Senior Consultant Breast Cancer, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · International Breast Cancer Study Group, Bern, Switzerland. · Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Institute of Radiotherapy, Klinik Hirslanden, Zürich, Switzerland. · Pubmed 27598802
  • Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA · Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne · University of Newcastle, Newcastle · Alan S. Coates, University of Sydney, Sydney, Australia · Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland · Gini F. Fleming, University of Chicago Medical Center, Chicago, IL · Barbara A. Walley, National Cancer Institute of Canada Clinical Trials Group, Calgary, Alberta, Canada · Giuseppe Viale, University of Milan · Giuseppe Viale, Marco Colleoni, and Aron Goldhirsch, European Institute of Oncology, Milan · Carlo Tondini, Ospedale Papa Giovanni XXIII, Bergamo · Graziella Pinotti, Ospedale di Circolo and Fondazione Macchi, Varese, Italy · István Láng, National Institute of Oncology, Budapest, Hungary · Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásticas, Lima, Peru. · Pubmed 27044936
  • Karin Ribi, Aron Goldhirsch, and Jürg Bernhard, International Breast Cancer Study Group Coordinating Center · Jürg Bernhard, Bern University Hospital, Inselspital, Bern · Thomas Ruhstaller, Breast Center St Gallen, Swiss Group for Clinical Cancer Research, and International Breast Cancer Study Group, St Gallen, Switzerland · Weixiu Luo, Karen N. Price, Richard D. Gelber, and Meredith M. Regan, International Breast Cancer Study Group Statistical Center · Weixiu Luo, Harold J. Burstein, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute · Harold J. Burstein, Alliance for Clinical Trials in Oncology · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber and Meredith M. Regan, Harvard Medical School, Boston, MA · Gini F. Fleming, The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL · Prudence A. Francis, International Breast Cancer Study Group, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria · Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle · Alan S. Coates, International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia · Eva Ciruelos, University Hospital 12 de Octubre and SOLTI Group, Madrid · Meritxell Bellet, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, and SOLTI Group, Universitat Autònoma de Barcelona, Barcelona · Ana Lluch, Hospital Clinico Universitario de Valencia, Incliva Biomedical Research Institute, University of Valencia and SOLTI Group, Valencia · Antonia Perelló, Hospital Universitari Son Espases and SOLTI Group, Palma de Mallorca, Spain · Lorenzo Pavesi, Salvatore Maugeri Foundation and International Breast Cancer Study Group, Pavia · Marilena Visini, Ospedale Civile di Lecco and International Breast Cancer Study Group, Lecco · Carlo Tondini, Ospedale Papa Giovanni XXIII and International Brea · Pubmed 27022111
  • Marco Colleoni and Aron Goldhirsch, European Institute of Oncology and International Breast Cancer Study Group, Milan · Lorenzo Gianni, Ospedale degli Infermi and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rimini, Italy · Zhuoxin Sun, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center and Frontier Science and Technology Research Foundation · Zhuoxin Sun and Richard D. Gelber, Harvard T.F. Chan School of Public Health · Richard D. Gelber, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Per Karlsson, Institute of Selected Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, Gothenburg, Sweden · John F. Forbes, Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle Mater Hospital, Newcastle · Alan S. Coates, International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia · Beat Thürlimann, Breast Center Kantonsspital, St Gallen, and Swiss Group for Clinical Cancer Research · and Monica Castiglione, International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 26786933
2015
  • Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Ave, Boston, MA, 02215, USA. · VM Institute of Research, 6100 Av Royalmount, Montréal, QC, H4P 2R2, Canada. · AKESOgen, Inc., 3155 Northwoods Pl NW, Norcross, GA, 30071, USA. · Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Genomic and Molecular Pathology, University of Chicago, 900 E 57th St. Room 1260D, Chicago, IL, 60637, USA. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Effingerstrasse 40, 3008, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Breast Center, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Auckland City Hospital, PO Box 26498, Epsom, Auckland, 1344, New Zealand. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, Australia. · Department of Oncology, Multidisciplinary Breast Center, KULeuven (University of Leuven), University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. · Institute Georges François Leclerc, 1 Rue Professeur Marion, BP 77 980, 21079, Dijon Cedex, France. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · Program for Breast Health (Senology), European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · Institute of Oncology of Southern Switzerland (IOSI), Ospedale Italiano, Via Capelli, 6962, Viganello, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Via Ripamonti 435, 20146, Milan, Italy. · Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, 1500 E Medical Cntr Drive/SPC 5946, Ann Arbor, MI, 48109, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA. · Pubmed 26590813
  • International Breast Cancer Study Group Coordinating Center and Bern University Hospital, Inselspital, Bern, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Dana-Farber Cancer Institute and Alliance for Clinical Trials in Oncology, Boston, MA, USA. · Medical Oncology, Osp Papa Giovanni XXIII and International Breast Cancer Study Group, Bergamo, Italy. · Medical Oncology, Ospedale di Circolo and Fondazione Macchi, and International Breast Cancer Study Group, Varese, Italy. · Medical Oncology, Centro di Riferimento Oncologico, and International Breast Cancer Study Group, Aviano, Italy. · Breast Center, Kantonsspital St Gallen, Swiss Group for Clinical Cancer Research (SAKK), and International Breast Cancer Study Group, St Gallen, Switzerland. · Department of Oncology, University Hospital of Udine, University of Udine and International Breast Cancer Study Group, Udine, Italy. · Oncology Unit, Salvatore Maugeri Foundation, and International Breast Cancer Study Group, Pavia, Italy. · Surgical Oncology, Breast Services, Tata Memorial Hospital, and International Breast Cancer Study Group, Mumbai, India. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research, and International Breast Cancer Study Group, Lugano Viganello, Switzerland. · University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne and Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia, and International Breast Cancer Study Group. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, Frontier Science and Technology Research Foundation, Boston, MA, USA. · Program for Breast Health (Senology), European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group, Bern, Switzerland. · Tom Baker Cancer Centre and National Cancer Institute of Canada Clinical Trials Group, Calgary, AB, Canada. · Pubmed 26092816
  • Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mailstop CLS-11007, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia. · Australia & New Zealand Breast Cancer Trials Group (ANZBCTG), University of Newcastle, Callaghan, NSW, Australia. · The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Tom Baker Cancer Centre and NCIC Clinical Trials Group, Calgary, AB, Canada. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Pathological Department, National Institute of Oncology, Budapest, Hungary. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Division of Pathology, Salvatore Maugeri Foundation, Pavia, Italy. · Struttura Operativa Complessa di Anatomia Patologica, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy. · Kantonsspital St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland. · University of Insubria-Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Department of Pathology, Vall d'Hebron University Hospital, SOLTI Group, Barcelona, Spain. · Pathology Department, Hospital Universitario «12 de Octubre», i+12, Universidad Complutense Madrid, SOLTI Group, Madrid, Spain. · Laboratoire Anatomopathologie, Institut Bergonié, Bordeaux, France. · EORTC, Brussels, Belgium. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Program for Breast Health, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 26493064
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, USA. · Institute of Cancer Sciences, Glasgow University, Glasgow. · Southern General Hospital, Glasgow, UK. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. · Breast Center, Kantonsspital, St Gallen Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Danish Breast Cancer Cooperative Group (DBCG), Rigshospitalet, Copenhagen, Denmark. · Department of Pathology, Institut Bergonié, Bordeaux. · Department of Pathology, Val d'Aurelle Cancer Institute, Montpellier, France. · Department of Pathology, Rigshospitalet, Copenhagen, Denmark. · International Breast Cancer Study Group (IBCSG) Statistical Center. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, USA Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, USA. · International Breast Cancer Study Group, Bern, Switzerland University of Sydney, Sydney, Australia. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26387144
  • Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute · Richard D. Gelber and Meredith M. Regan, Harvard Medical School · Karen N. Price, Frontier Science and Technology Research, Boston, MA · Elizabeth Mallon, Southern General Hospital · Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom · Giuseppe Viale, European Institute of Oncology and University of Milan · Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy · Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland · Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark · Marc Debled, Institut Bergoniié, Bordeaux, France · and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Pubmed 26215945
  • International Breast Cancer Study Group, University of Sydney, Sydney, Australia. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · International Breast Cancer Study Group, Program of Breast Health (Senology), European Institute of Oncology, Milan, Italy · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Internal Medicine/Oncology, Institut Jules Bordet, Brussels, Belgium. · Breast Center, Kantonsspital St Gallen, St Gallen. · Tumor and Breast Center ZeTuP, St Gallen, Switzerland. · Pubmed 25939896
2014
  • Luzerner Kantonsspital, Lucerne, Switzerland; University of Berne, Berne, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. · National Institute of Oncology, Budapest, Hungary. · Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Leids Universitair Medisch Centrum, Leiden, Netherlands. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Baylor College of Medicine, Houston, TX, USA. · Hospital Puerta Del Mar, Cádiz, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland; Breast Center, Kantonsspital, St Gallen, Switzerland. · Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. · MD Anderson Cancer Center, Orlando, FL, USA. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · International Breast Cancer Study Group, Bern, Switzerland; University of Sydney, Sydney, Australia. · University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Stanford University School of Medicine, Stanford, CA, USA. · Pubmed 24439313
2013
  • Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy. Electronic address: · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard School of Public Health, Boston, MA, USA. · Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Department of Medical and Biological Sciences, Medical Oncology, University of Udine, Udine, Italy. · Quality of Life Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Institute of Oncology, Budapest, Hungary. · Department of Oncology, Ospedale Infermi Rimini and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rimini, Italy. · Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy. · Medical Oncology, Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Medical Oncology, Spital STS AG, Thun, Switzerland. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard School of Public Health, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · Unité de Onco-Gynécologie médicale, Departement de Médecine Hôpitaux, Universitaires de Genève, Genève, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Department of Medical Oncology, Inselspital, Bern, Switzerland. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23453899
2012
  • International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22355052
2018
  • From the Peter MacCallum Cancer Centre, St. Vincent's Hospital, University of Melbourne, Melbourne, VIC, and Breast Cancer Trials Australia and New Zealand, University of Newcastle, Newcastle, NSW (P.A.F.), and the University of Sydney, Sydney (A.S.C.) - all in Australia · the Institute of Oncology of Southern Switzerland, Ospedale San Giovanni, Bellinzona (O.P.), Breast Cancer St. Gallen, St. Gallen (T.R.), and the International Breast Cancer Study Group Coordinating Center (R.M., M.R.-P., B.R., A.S.C.), University Hospital Inselspital (M.R.-P.), Bern - all in Switzerland · the University of Chicago Medical Center, Chicago (G.F.F.) · the University of Calgary, Calgary, AB, Canada (B.A.W.) · the Division of Medical Senology, European Institute of Oncology (M.C.), and the European Institute of Oncology and International Breast Cancer Study Group (A.G.), Milan, Ospedale Papa Giovanni XXIII, Bergamo (C.T.), Azienda Socio Sanitaria Territoriale Sette Laghi-Ospedale di Circolo and Fondazione Macchi, Varese (G.P.), Medical Oncology and Cancer Prevention, IRCCS, National Cancer Institute, Aviano (F.P., S.S.), the Department of Medicine, School of Medical Oncology, University of Udine, Udine (F.P.), Salvatore Maugeri Foundation, Pavia (L.P.), and the Hospital of Prato-Azienda Unità Sanitaria Locale Toscana Centro, Prato (A.D.L.) - all in Italy · the National Institute of Oncology, Budapest, Hungary (I.L.) · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.) · University Hospital 12 de Octubre, Madrid (E.C.), Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona (M.B.), and Instituto Valenciano de Oncologia, Valencia (M.A.C.) - all in Spain · the Susan F. Smith Center for Women's Cancers (H.J.B., E.P.W.) and the International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology (R.D.G., M.M.R.), Dana-Farber Cancer Institute, Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Frontier Science and Technology Research Foundation (R.D.G.) - all in Boston · Institut Bergonié Comprehensive Cancer Center, Université de Bordeaux, Bordeaux, France (H.R.B., M.D.) · the Angeles Clinic and Research Institute, Santa Monica, CA (S.M.) · Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond (C.E.G.) · Mayo Clinic, Rochester, MN (M.P.G., J.N.I.) · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (V.S.) · Fred Hutchinson Cancer Research Center, University of Washington, Seattle (N.E.D.) · Weston Park Hospital, Sheffield, United Kingdom (R.C.) · and the Department of Obstetrics and Gynecology, University Medical Center, Regensburg, Germany (S.B.). · Pubmed 29863451
2016
  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 3002, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Platt Street, Waratah, NSW 2298, Australia. · International Breast Cancer Study Group, Bern CH-3008, Switzerland. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Harvard Medical School, Department of Medicine, Boston, MA 02115, USA. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, Bern CH-3008, Switzerland. · Department of Medical Oncology, University Hospital of Udine, Piazzale S.M. Misericordia 15, Udine 33100, Italy. · School of Medical Oncology, The University of Udine, Udine 33100, Italy. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona 08035, Spain. · SOLTI Group, Barcelona 08008, Spain. · CRO Aviano, IRCCS, National Cancer Institute, Via F. Gallini 2, Aviano 33081, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Röda stråket 16, Gothenburg 413 45, Sweden. · Monter Cancer Center of the North Shore-LIJ Health System, 450 Lakeville Road, Lake Success, NY 11042, USA. · NRG Oncology, Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103, USA. · Department of Oncology, Breast Center CHUV, Rue du Bugnon 46, Lausanne 1011, Switzerland. · Tweed Heads Hospital, Tweed Heads, Griffith University, Gold Coast, Powell Street, Tweed Heads, NSW 2485, Australia. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA. · ECOG-ACRIN, 1818 Market Street, Suite 1100, Philadelphia, PA 19103, USA. · Frontier Science and Technology Research Foundation. · University of Sydney, Sydney, NSW 2006, Australia. · Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA 02115, USA. · Cogstate Ltd, 2/255 Bourke Street, Melbourne, VIC 3000, Australia. · Mater Hospital, 40 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Newcastle, Calvary Mater Newcastle Hospital, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), NBN Telethon Mater Institute, Locked Bag 7 HRMC, Newcastle, NSW 2298, Australia. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Ave Fl 7, New York, NY 10022, USA. · Alliance for Clinical Trials in Oncology, Chicago, IL 60637, USA. · The University of Chicago Medical Center, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637, USA. · Inselspital, Bern University Hospital, Bern CH-3010, Switzerland. · Pubmed 27092785
2011
  • National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW 1450, Australia. · Pubmed 22025143
  • NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW 1450, Australia. · Pubmed 21445568
Probable:    International Breast Cancer Study Group      
2018
  • National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Locked Bag 7, Camperdown, NSW, 1450, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · International Breast Cancer Study Group and Inselspital, Bern University Hospital, Bern, Switzerland. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Locked Bag 7, Camperdown, NSW, 1450, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 29329582
2017
  • James P. Morden, Lucy Kilburn, Claire Snowdon, and Judith M. Bliss, The Institute of Cancer Research · Hanna Nicholas, Cancer Research UK · R. Charles Coombes, Imperial College London, London · Gianfilippo Bertelli, Singleton Hospital, Swansea · Robert Coleman, Weston Park Hospital, Sheffield · Lesley Fallowfield, University of Sussex, Brighton · David Dodwell, St James Hospital, Leeds, United Kingdom · Isabel Alvarez, Hospital Donostia, GEICAM Spanish Breast Cancer Group, San Sebastian, Spain · Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia · Jacek Jassem, Medical University of Gdansk, Gdansk, Poland · Stephen Jones, US Oncology Research, The Woodlands, TX · Per E. Lønning, University of Bergen and Haukeland University Hospital, Bergen, Norway · Olaf Ortmann, University Medical Center Regensburg, Regensburg, Germany · Cornelis van de Velde, Leiden University Medical Centre, Leiden, the Netherlands · Jørn Andersen, Aarhus University Hospital, Aarhus, Denmark · Lucia Del Mastro, IRCCS Azienda Ospedaliera Universitaria San Martino IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy · Stig Holmberg, Sahlgrenska Universitetssjukhuset, Goteborg, Sweden · and Robert Paridaens, Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium. · Pubmed 28467729
  • NRG Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. · NRG Oncology and University of Florida Health Cancer Center at Orlando Health, Orlando, FL, USA. · NRG Oncology and Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada. · GEICAM, Instituto de Investigacion SanitariaGregorio Marañon, Universidad Complutense, Madrid, Spain. · BOOG, Dutch Breast Cancer Trialists' Group, Leids Universitair Medisch Centrum, Leiden, Netherlands. · NRG Oncology and Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · NRG Oncology and Tom Baker Cancer Centre, Calgary, Alberta, Canada. · IBCSG and National Institute of Oncology, Budapest, Hungary. · IBCSG, Bern, Switzerland and University of Sydney, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · NRG Oncology and the Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · IBCSG, Luzerner Kantonsspital, Lucerne and University of Berne, Switzerland and Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Pubmed 27663567
2015
  • Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Ave, Boston, MA, 02215, USA. · VM Institute of Research, 6100 Av Royalmount, Montréal, QC, H4P 2R2, Canada. · AKESOgen, Inc., 3155 Northwoods Pl NW, Norcross, GA, 30071, USA. · Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Genomic and Molecular Pathology, University of Chicago, 900 E 57th St. Room 1260D, Chicago, IL, 60637, USA. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Effingerstrasse 40, 3008, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Breast Center, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Auckland City Hospital, PO Box 26498, Epsom, Auckland, 1344, New Zealand. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, Australia. · Department of Oncology, Multidisciplinary Breast Center, KULeuven (University of Leuven), University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. · Institute Georges François Leclerc, 1 Rue Professeur Marion, BP 77 980, 21079, Dijon Cedex, France. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · Program for Breast Health (Senology), European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · Institute of Oncology of Southern Switzerland (IOSI), Ospedale Italiano, Via Capelli, 6962, Viganello, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Via Ripamonti 435, 20146, Milan, Italy. · Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, 1500 E Medical Cntr Drive/SPC 5946, Ann Arbor, MI, 48109, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA. · Pubmed 26590813
  • Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mailstop CLS-11007, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia. · Australia & New Zealand Breast Cancer Trials Group (ANZBCTG), University of Newcastle, Callaghan, NSW, Australia. · The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Tom Baker Cancer Centre and NCIC Clinical Trials Group, Calgary, AB, Canada. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Pathological Department, National Institute of Oncology, Budapest, Hungary. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Division of Pathology, Salvatore Maugeri Foundation, Pavia, Italy. · Struttura Operativa Complessa di Anatomia Patologica, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy. · Kantonsspital St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland. · University of Insubria-Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Department of Pathology, Vall d'Hebron University Hospital, SOLTI Group, Barcelona, Spain. · Pathology Department, Hospital Universitario «12 de Octubre», i+12, Universidad Complutense Madrid, SOLTI Group, Madrid, Spain. · Laboratoire Anatomopathologie, Institut Bergonié, Bordeaux, France. · EORTC, Brussels, Belgium. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Program for Breast Health, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 26493064
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, USA. · Institute of Cancer Sciences, Glasgow University, Glasgow. · Southern General Hospital, Glasgow, UK. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. · Breast Center, Kantonsspital, St Gallen Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Danish Breast Cancer Cooperative Group (DBCG), Rigshospitalet, Copenhagen, Denmark. · Department of Pathology, Institut Bergonié, Bordeaux. · Department of Pathology, Val d'Aurelle Cancer Institute, Montpellier, France. · Department of Pathology, Rigshospitalet, Copenhagen, Denmark. · International Breast Cancer Study Group (IBCSG) Statistical Center. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, USA Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, USA. · International Breast Cancer Study Group, Bern, Switzerland University of Sydney, Sydney, Australia. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26387144
  • Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute · Richard D. Gelber and Meredith M. Regan, Harvard Medical School · Karen N. Price, Frontier Science and Technology Research, Boston, MA · Elizabeth Mallon, Southern General Hospital · Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom · Giuseppe Viale, European Institute of Oncology and University of Milan · Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy · Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland · Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark · Marc Debled, Institut Bergoniié, Bordeaux, France · and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Pubmed 26215945
2014
  • Luzerner Kantonsspital, Lucerne, Switzerland; University of Berne, Berne, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. · National Institute of Oncology, Budapest, Hungary. · Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Leids Universitair Medisch Centrum, Leiden, Netherlands. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Baylor College of Medicine, Houston, TX, USA. · Hospital Puerta Del Mar, Cádiz, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland; Breast Center, Kantonsspital, St Gallen, Switzerland. · Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. · MD Anderson Cancer Center, Orlando, FL, USA. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · International Breast Cancer Study Group, Bern, Switzerland; University of Sydney, Sydney, Australia. · University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Stanford University School of Medicine, Stanford, CA, USA. · Pubmed 24439313
2018
  • From the Peter MacCallum Cancer Centre, St. Vincent's Hospital, University of Melbourne, Melbourne, VIC, and Breast Cancer Trials Australia and New Zealand, University of Newcastle, Newcastle, NSW (P.A.F.), and the University of Sydney, Sydney (A.S.C.) - all in Australia · the Institute of Oncology of Southern Switzerland, Ospedale San Giovanni, Bellinzona (O.P.), Breast Cancer St. Gallen, St. Gallen (T.R.), and the International Breast Cancer Study Group Coordinating Center (R.M., M.R.-P., B.R., A.S.C.), University Hospital Inselspital (M.R.-P.), Bern - all in Switzerland · the University of Chicago Medical Center, Chicago (G.F.F.) · the University of Calgary, Calgary, AB, Canada (B.A.W.) · the Division of Medical Senology, European Institute of Oncology (M.C.), and the European Institute of Oncology and International Breast Cancer Study Group (A.G.), Milan, Ospedale Papa Giovanni XXIII, Bergamo (C.T.), Azienda Socio Sanitaria Territoriale Sette Laghi-Ospedale di Circolo and Fondazione Macchi, Varese (G.P.), Medical Oncology and Cancer Prevention, IRCCS, National Cancer Institute, Aviano (F.P., S.S.), the Department of Medicine, School of Medical Oncology, University of Udine, Udine (F.P.), Salvatore Maugeri Foundation, Pavia (L.P.), and the Hospital of Prato-Azienda Unità Sanitaria Locale Toscana Centro, Prato (A.D.L.) - all in Italy · the National Institute of Oncology, Budapest, Hungary (I.L.) · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.) · University Hospital 12 de Octubre, Madrid (E.C.), Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona (M.B.), and Instituto Valenciano de Oncologia, Valencia (M.A.C.) - all in Spain · the Susan F. Smith Center for Women's Cancers (H.J.B., E.P.W.) and the International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology (R.D.G., M.M.R.), Dana-Farber Cancer Institute, Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Frontier Science and Technology Research Foundation (R.D.G.) - all in Boston · Institut Bergonié Comprehensive Cancer Center, Université de Bordeaux, Bordeaux, France (H.R.B., M.D.) · the Angeles Clinic and Research Institute, Santa Monica, CA (S.M.) · Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond (C.E.G.) · Mayo Clinic, Rochester, MN (M.P.G., J.N.I.) · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (V.S.) · Fred Hutchinson Cancer Research Center, University of Washington, Seattle (N.E.D.) · Weston Park Hospital, Sheffield, United Kingdom (R.C.) · and the Department of Obstetrics and Gynecology, University Medical Center, Regensburg, Germany (S.B.). · Pubmed 29863451
2016
  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 3002, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Platt Street, Waratah, NSW 2298, Australia. · International Breast Cancer Study Group, Bern CH-3008, Switzerland. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Harvard Medical School, Department of Medicine, Boston, MA 02115, USA. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, Bern CH-3008, Switzerland. · Department of Medical Oncology, University Hospital of Udine, Piazzale S.M. Misericordia 15, Udine 33100, Italy. · School of Medical Oncology, The University of Udine, Udine 33100, Italy. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona 08035, Spain. · SOLTI Group, Barcelona 08008, Spain. · CRO Aviano, IRCCS, National Cancer Institute, Via F. Gallini 2, Aviano 33081, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Röda stråket 16, Gothenburg 413 45, Sweden. · Monter Cancer Center of the North Shore-LIJ Health System, 450 Lakeville Road, Lake Success, NY 11042, USA. · NRG Oncology, Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103, USA. · Department of Oncology, Breast Center CHUV, Rue du Bugnon 46, Lausanne 1011, Switzerland. · Tweed Heads Hospital, Tweed Heads, Griffith University, Gold Coast, Powell Street, Tweed Heads, NSW 2485, Australia. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA. · ECOG-ACRIN, 1818 Market Street, Suite 1100, Philadelphia, PA 19103, USA. · Frontier Science and Technology Research Foundation. · University of Sydney, Sydney, NSW 2006, Australia. · Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA 02115, USA. · Cogstate Ltd, 2/255 Bourke Street, Melbourne, VIC 3000, Australia. · Mater Hospital, 40 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Newcastle, Calvary Mater Newcastle Hospital, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), NBN Telethon Mater Institute, Locked Bag 7 HRMC, Newcastle, NSW 2298, Australia. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Ave Fl 7, New York, NY 10022, USA. · Alliance for Clinical Trials in Oncology, Chicago, IL 60637, USA. · The University of Chicago Medical Center, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637, USA. · Inselspital, Bern University Hospital, Bern CH-3010, Switzerland. · Pubmed 27092785
2013
  • International Breast Cancer Study Group, Division of Medical Oncology, European Institute of Oncology, Milan, Italy. · Pubmed 23917950
2012
  • IBCSG Coordinating Center, Effingerstr. 40, Bern 3008, Switzerland. · Pubmed 22531635
2011
  • International Breast Cancer Study Group, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 21709140
Probable:    McMaster University   Contact    
2014
  • Department of Surgery, McMaster University and St Joseph's Healthcare, 50 Charlton Avenue East, G802, Hamilton, ON L8N 4A6, Canada. Electronic address: · Department of Surgery, McMaster University and St Joseph's Healthcare, 50 Charlton Avenue East, G802, Hamilton, ON L8N 4A6, Canada; Department of Surgical Oncology, Hamilton Health Sciences and Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada. · Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada. · Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada; Biostatistics Unit, St Joseph's Healthcare, Hamilton, ON, Canada. · Department of Surgery, McMaster University and St Joseph's Healthcare, 50 Charlton Avenue East, G802, Hamilton, ON L8N 4A6, Canada. · Department of Surgery, McMaster University and St Joseph's Healthcare, 50 Charlton Avenue East, G802, Hamilton, ON L8N 4A6, Canada; Department of Surgical Oncology, Hamilton Health Sciences and Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada. · Pubmed 24315382
2014
  • Department of Surgery, McMaster University, G802, St. Joseph's Healthcare 50 Charlton Avenue East, Hamilton, ON, L8N 4A6, Canada, · Pubmed 24595798
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 58 total) written by Alan S. Coates about Breast Neoplasms:

  • Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. 2018
  • Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00. 2018
  • Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. 2018
  • Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. 2018
  • Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial. 2018
  • When do patient reported quality of life indicators become prognostic in breast cancer? 2018
  • Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al. 2018
  • Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT. 2017
  • Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study. 2017
  • Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. 2017
Show List of Full Article Records
Google Searches

Learn more about Alan S. Coates using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Sydney
International Breast Cancer Study Group
McMaster University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Sydney
2018
  • Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: · IBCSG Statistical Center and Department of Mathematics and Statistics, University of Vermont, Burlington, VT, USA. · International Breast Cancer Study Group (IBCSG) Central Pathology Office, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. · Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. · Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Central Pathology Office, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy. · Centro di Riferimento Oncologico, Aviano, Italy. · Department of Surgical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Orsola Hospital and University of Bologna, Bologna, Italy. · Riverina Cancer Care Centre, Wagga Wagga, NSW, Australia. · Breast Center St Gallen, Kantonsspital, St Gallen, Switzerland. · Department of Medical Oncology, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · IBCSG and University of Sydney, Sydney, NSW, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · IBCSG and European Institute of Oncology, Milan, Italy. · Pubmed 30196031
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, and Harvard T.H Chan School of Public Health, Boston, MA, USA. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, Department of Oncology and Hemato-oncology, European Institute of Oncology and University of Milan, Milan, Italy. · National Institute of Oncology, Budapest, Hungary. · Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Rimini, Dipartimento di Oncologia ed Ematologia, AUSL della Romagna, Rimini, Italy. · Translational Research Coordination and Central Pathology Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan and International Breast Cancer Study Group Central Pathology Office, Milan, Italy. · Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, and International Breast Cancer Study Group, Prato, Italy. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School and Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Scientific & Clinical Evaluation Board, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, and International Breast Cancer Study Group, Milan, Italy. · Pubmed 29589138
  • International Breast Cancer Study Group, Milan, Italy; Division of Medical Senology, Milan, Italy. Electronic address: · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA. · International Breast Cancer Study Group and Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · International Breast Cancer Study Group, Australia and New Zealand Breast Cancer Trials Group, and Box Hill and Maroondah Hospitals, Monash University, Melbourne, VIC, Australia. · International Breast Cancer Study Group and Lucerne Canton Hospital, Lucerne, Switzerland. · International Breast Cancer Study Group, Centre Hospitalier Universitaire de Liège, Liège University, Liège, Belgium. · International Breast Cancer Study Group and Multidisciplinary Breast Center, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium. · International Breast Cancer Study Group and National Institute of Oncology, Budapest, Hungary. · International Breast Cancer Study Group and Centre Hospitalier Chrétien Clinique St Joseph, Liège, Belgium. · International Breast Cancer Study Group and ASST Spedali Civili di Brescia, Brescia, Italy. · Danish Breast Cancer Group and Rigshospitalet, Copenhagen, Denmark. · Scottish Cancer Trials Breast Group and The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · German Breast Group, Neu-Isenburg, Germany. · SOLTI Group and Fundación Instituto Valenciano de Oncologia, Valencia, Spain. · Japan Breast Cancer Research Group and Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. · Austrian Breast & Colorectal Cancer Study Group and Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria. · Chilean Cooperative Group for Oncologic Research, Providencia, Santiago, Chile. · Cancer Trials Ireland and Cork University Hospital, Cork, Ireland. · International Breast Cancer Study Group and Centro di Riferimento Oncologico di Aviano, Aviano, Italy. · Medical Oncology Clinic, Institute Jules Bordet, Brussels, Belgium. · Swiss Group for Clinical Cancer Research, International Breast Cancer Study Group, and Breast Center St Gallen, St Gallen, Switzerland. · Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Central Pathology Office and University of Milan, Milan, Italy. · International Breast Cancer Study Group, Inselspital, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia. · International Breast Cancer Study Group and Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group, Milan, Italy; European Institute of Oncology, Milan, Italy. · Pubmed 29158011
  • Irene L. Wapnir, Stanford University School of Medicine, Stanford, CA · Karen N. Price and Shari Gelber, Frontier Science and Technology Research Foundation, Richard D. Gelber, Frontier Science and Technology Research Foundation, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, Meredith M. Regan, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · Stewart J. Anderson, University of Pittsburgh Graduate School of Public Health · Priya Rastogi, University of Pittsburgh Cancer Institute · Norman Wolmark, Allegheny Health Network Cancer Institute, Pittsburgh, PA · André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec · Alexander H.G. Paterson, Tom Baker Cancer Centre, Calgary, Alberta, Canada · Miguel Martín, CIBERONC, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Madrid · José Manuel Baena-Cañada, Hospital Puerta del Mar, Cádiz, Spain · Johan W.R. Nortier, Leids Universitair Medisch Centrum, Leiden, Netherlands · Mothaffar F. Rimawi, Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX · István Láng, National Institute of Oncology, Budapest, Hungary · Beat Thürlimann, Kantonsspital, St. Gallen · Stefan Aebi, Lucerne Cantonal Hospital and University of Bern, Switzerland · Eleftherios P. Mamounas, Orlando Health University of Florida Health Cancer Center, Orlando, FL · Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA · and Alan S. Coates, University of Sydney, Sydney, Australia. · Pubmed 29443653
  • National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Locked Bag 7, Camperdown, NSW, 1450, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · International Breast Cancer Study Group and Inselspital, Bern University Hospital, Bern, Switzerland. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Locked Bag 7, Camperdown, NSW, 1450, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 29329582
  • International Breast Cancer Study Group (IBCSG) Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · International Breast Cancer Study Group, Data Management Center, Amherst, NY, USA. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center and Bern University Hospital, Inselspital, Bern, Switzerland. · Pubmed 28875248
2017
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston. · International Breast Cancer Study Group Statistical Center, Boston, USA. · University of Calgary and Canadian Cancer Trials Group, Calgary, Canada. · Division of Cancer Medicine, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne. · Australia & New Zealand Breast Cancer Trials Group and International Breast Cancer Study Group, Melbourne, Australia. · The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, USA. · National Institute of Oncology and International Breast Cancer Study Group, Medical Oncology, Budapest, Hungary. · Division of Medicine, Instituto Nacional de Enfermedades Neoplásicas and International Breast Cancer Study Group, Lima, Peru. · Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan. · Medical Oncology, Ospedale Papa Giovanni XXIII and International Breast Cancer Study Group, Bergamo. · Medical Oncology, ASST Sette Laghi-Ospedale di Circolo and Fondazione Macchi and International Breast Cancer Study Group, Varese, Italy. · Allan Blair Cancer Center, Regina, Canada. · Medical Oncology, Centro di Riferimento Oncologico and International Breast Cancer Study Group, Aviano, Italy. · Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre and International Breast Cancer Study Group, Mumbai, India. · Breast Center St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen. · International Breast Cancer Study Group, St. Gallen, Switzerland. · Australia & New Zealand Breast Cancer Trials Group and International Breast Cancer Study Group, The Tweed Hospital, Griffith University Gold Coast, Tweed Heads, Australia. · Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, Boston, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Oncology Institute of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bellinzona. · International Breast Cancer Study Group, Lugano, Viganello, Switzerland. · Pubmed 28911092
  • Signe Borgquist and Judy E. Garber, Dana-Farber Cancer Institute, Harvard Medical School · Anita Giobbie-Hurder, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute · Richard D. Gelber, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, T.H. Chan Harvard School of Public Health, and Frontier Science and Technology Research Foundation · Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation · Meredith M. Regan, IBCSG Statistical Center, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA · Signe Borgquist, Lund University, Lund, Sweden · Thomas P. Ahern, University of Vermont, Burlington, VT · Marco Colleoni and Aron Goldhirsch, IBCSG and European Institute of Oncology, Milan, Italy · István Láng, IBCSG and National Institute of Oncology, Budapest, Hungary · Marc Debled, Institut Bergonié, Bordeaux, France · Bent Ejlertsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark · Roger von Moos, Cantonal Hospital Graubuenden, Chur · Swiss Group for Clinical Cancer Research and IBCSG · Manuela Rabaglio, IBCSG Coordinating Center and Inselspital, Bern · Beat Thürlimann, Breast Center St. Gallen, Kantonsspital, St. Gallen · Swiss Group for Clinical Cancer Research and IBCSG, Bern, Switzerland · Ian Smith, The Royal Marsden Hospital, London, United Kingdom · and Alan S. Coates, IBCSG and University of Sydney School of Public Health, Sydney, Australia. · Pubmed 28380313
  • Poornima Saha and Gini F. Fleming, The University of Chicago Medical Center, Chicago, IL · Meredith M. Regan, Weixiu Luo, Harold J. Burstein, and Richard D. Gelber, Dana-Farber Cancer Institute · Meredith M. Regan, Harold J. Burstein, and Richard D. Gelber, Harvard Medical School · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA · Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello · Karin Ribi and Jürg Bernhard, International Breast Cancer Study Group Coordinating Center · Jürg Bernhard, Bern University Hospital, Inselspital, Bern, Switzerland · Prudence A. Francis, Peter MacCallum Cancer Center · St Vincent's Hospital · University of Melbourne, Melbourne · Josephine Stewart, Austin and Heidelberg Repatriation Medical Center, Heidelberg, Victoria · Prudence A. Francis, Josephine Stewart, and Michelle Nottage, University of Newcastle, Newcastle · Alan S. Coates, University of Sydney, Sydney, New South Wales · Michelle Nottage, Royal Brisbane Hospital, Brisbane, Queensland, Australia · Barbara A. Walley, University of Calgary · National Cancer Institute of Canada, Calgary, Alberta, Canada · Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru · Vani Parmar, Tata Memorial Centre, Mumbai, India · Roberto Torres, Instituto Nacional del Cancer, Santiago de Chile, Chile · Meritxell Bellet, Vall d'Hebron Institute of Oncology · Vall d'Hebron University Hospital · Universitat Autònoma de Barcelona, Barcelona · Antonia Perelló, Hospital Universitari Son Espases, Palma de Mallorca, Spain · Faysal Dane, Marmara University Hospital, Istanbul, Turkey · Antonio Moreira, Instituto Português de Oncologia Francisco Gentil - Centro de Lisboa, Lisbon, Portugal · Daniel Vorobiof, Sandton Oncology Centre, Johannesburg, South Africa · and Aron Goldhirsch and Marco Colleoni, European Institute of Oncology, Milan, Italy. · Pubmed 28654365
  • James P. Morden, Lucy Kilburn, Claire Snowdon, and Judith M. Bliss, The Institute of Cancer Research · Hanna Nicholas, Cancer Research UK · R. Charles Coombes, Imperial College London, London · Gianfilippo Bertelli, Singleton Hospital, Swansea · Robert Coleman, Weston Park Hospital, Sheffield · Lesley Fallowfield, University of Sussex, Brighton · David Dodwell, St James Hospital, Leeds, United Kingdom · Isabel Alvarez, Hospital Donostia, GEICAM Spanish Breast Cancer Group, San Sebastian, Spain · Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia · Jacek Jassem, Medical University of Gdansk, Gdansk, Poland · Stephen Jones, US Oncology Research, The Woodlands, TX · Per E. Lønning, University of Bergen and Haukeland University Hospital, Bergen, Norway · Olaf Ortmann, University Medical Center Regensburg, Regensburg, Germany · Cornelis van de Velde, Leiden University Medical Centre, Leiden, the Netherlands · Jørn Andersen, Aarhus University Hospital, Aarhus, Denmark · Lucia Del Mastro, IRCCS Azienda Ospedaliera Universitaria San Martino IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy · Stig Holmberg, Sahlgrenska Universitetssjukhuset, Goteborg, Sweden · and Robert Paridaens, Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium. · Pubmed 28467729
  • NRG Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. · NRG Oncology and University of Florida Health Cancer Center at Orlando Health, Orlando, FL, USA. · NRG Oncology and Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada. · GEICAM, Instituto de Investigacion SanitariaGregorio Marañon, Universidad Complutense, Madrid, Spain. · BOOG, Dutch Breast Cancer Trialists' Group, Leids Universitair Medisch Centrum, Leiden, Netherlands. · NRG Oncology and Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · NRG Oncology and Tom Baker Cancer Centre, Calgary, Alberta, Canada. · IBCSG and National Institute of Oncology, Budapest, Hungary. · IBCSG, Bern, Switzerland and University of Sydney, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · NRG Oncology and the Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · IBCSG, Luzerner Kantonsspital, Lucerne and University of Berne, Switzerland and Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Pubmed 27663567
2016
  • Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology · Giuseppe Viale, University of Milan, Milan · Lorenzo Gianni, Ospedale degli Infermi, Rimini · Fabio Puglisi, University Hospital of Udine, University of Udine, Udine · Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo · Katia Cagossi, Ospedale di Carpi, Carpi, Italy · Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center · Kathryn P. Gray, Shari Gelber, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute · Kathryn P. Gray and Richard D. Gelber, Harvard T.H. Chan School of Public Health · Richard D. Gelber and Meredith M. Regan, Harvard Medical School · Richard D. Gelber and Karen N. Price, Frontier Science and Technology Foundation, Boston, MA · István Láng, National Institute of Oncology, Budapest, Hungary · Beat Thürlimann, Kantonsspital, St Gallen · Beat Thürlimann, Elena Kralidis, and Daniel Rauch, Swiss Group for Clinical Cancer Research, Bern · Elena Kralidis, Kantonsspital Aarau, Aarau · Daniel Rauch, Spital Thun, Thun, Switzerland · Ehtesham A. Abdi, The Tweed Head Hospital, Tweed Heads, New South Wales and Griffith University, Southport, Queensland · Ehtesham A. Abdi and Jacquie Chirgwin, Australia and New Zealand Breast Cancer Trials Group · Jacquie Chirgwin, Box Hill and Maroondah Hospitals and Monash University, Melbourne, Victoria · Alan S. Coates, International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, New South Wales, Australia · Henry L. Gomez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru · Barbro K. Linderholm, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden · and Alexandru Eniu, Cancer Institute Ion Chiricuta, Cluj, Romania. · Pubmed 27325862
  • Jacquie H. Chirgwin and John F. Forbes, University of Newcastle · John F. Forbes, Calvary Mater Newcastle, Newcastle · Alan S. Coates, University of Sydney School of Public Health, Sydney, New South Wales · Jacquie H. Chirgwin, Box Hill Hospital · Jacquie H. Chirgwin, Maroondah Hospital · Jacquie H. Chirgwin, Monash University, Melbourne, Victoria, Australia · Anita Giobbie-Hurder, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard Medical School, Boston, MA · Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark · Marc Debled, Institut Bergonié, Bordeaux, France · Aron Goldhirsch and Marco Colleoni, European Institute of Oncology, Milan, Italy · Ian Smith, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom · Manuela Rabaglio, Inselspital, Bern · Beat Thürlimann, Kantonsspital, St. Gallen, Switzerland · Patrick Neven, University of Leuven · Patrick Neven, University Hospitals Leuven, Leuven, Belgium · István Láng, National Institute of Oncology, Budapest, Hungary. · Pubmed 27217455
  • Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia · Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia. · Australia and New Zealand Breast Cancer Trials Group, Waratah School of Medicine and Public Health, University of Newcastle, Callaghan, Australia Patricia Ritchie Centre for Cancer Care and Research, North Sydney. · Ballarat Oncology and Haematology, Wendouree. · Department of Surgery, Royal Adelaide Hospital, Adelaide. · Department of Medical Oncology, Royal Perth Hospital, Perth. · School of Surgery, University of Western Australia, Crawley. · Southern Highlands Cancer Centre, Bowral. · Department of Surgery, St John of God Hospital, Bunbury, Australia. · Breast Care Centre, Waikato Hospital, Hamilton, New Zealand. · Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville. · Australia and New Zealand Breast Cancer Trials Group, Waratah National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown, Australia. · Australia and New Zealand Breast Cancer Trials Group, Waratah. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Pubmed 26861603
  • Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Avenue, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Swiss Group for Clinical Cancer Research SAKK, Lugano Viganello, Switzerland. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Via Ripamonti 435, Milan, 20141, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · International Breast Cancer Study Group (IBCSG) Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · IBCSG Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · Dana-Farber Cancer Institute, Department of Biostatistics and Computatonal Biology, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, 450 Brookline Avenue, Boston, MA, 02215, USA. · Program for Breast Health, European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy. · Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Effingerstrasse 40, Bern, CH-3008, Switzerland. · Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · National Cancer Institute of Canada, Kingston, ON, Canada. · Pubmed 27825388
  • Department of Oncology, Institute of Clinical Sciences, Sahgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: · Department of Mathematics and Statistics, University of Vermont, Burlington, Vermont. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, Massachusetts. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Frontier Science and Technology Research Foundation, Harvard T. F. Chan School of Public Health, Boston, Massachusetts. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · Senior Consultant Breast Cancer, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · International Breast Cancer Study Group, Bern, Switzerland. · Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Institute of Radiotherapy, Klinik Hirslanden, Zürich, Switzerland. · Pubmed 27598802
  • Meredith M. Regan and Richard D. Gelber, Dana-Farber Cancer Institute, Harvard Medical School · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber, Harvard T.H. Chan School of Public Health, Boston, MA · Prudence A. Francis, MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne · University of Newcastle, Newcastle · Alan S. Coates, University of Sydney, Sydney, Australia · Olivia Pagani, Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland · Gini F. Fleming, University of Chicago Medical Center, Chicago, IL · Barbara A. Walley, National Cancer Institute of Canada Clinical Trials Group, Calgary, Alberta, Canada · Giuseppe Viale, University of Milan · Giuseppe Viale, Marco Colleoni, and Aron Goldhirsch, European Institute of Oncology, Milan · Carlo Tondini, Ospedale Papa Giovanni XXIII, Bergamo · Graziella Pinotti, Ospedale di Circolo and Fondazione Macchi, Varese, Italy · István Láng, National Institute of Oncology, Budapest, Hungary · Henry L. Gómez, Instituto Nacional de Enfermedades Neoplásticas, Lima, Peru. · Pubmed 27044936
  • Karin Ribi, Aron Goldhirsch, and Jürg Bernhard, International Breast Cancer Study Group Coordinating Center · Jürg Bernhard, Bern University Hospital, Inselspital, Bern · Thomas Ruhstaller, Breast Center St Gallen, Swiss Group for Clinical Cancer Research, and International Breast Cancer Study Group, St Gallen, Switzerland · Weixiu Luo, Karen N. Price, Richard D. Gelber, and Meredith M. Regan, International Breast Cancer Study Group Statistical Center · Weixiu Luo, Harold J. Burstein, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute · Harold J. Burstein, Alliance for Clinical Trials in Oncology · Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation · Richard D. Gelber and Meredith M. Regan, Harvard Medical School, Boston, MA · Gini F. Fleming, The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL · Prudence A. Francis, International Breast Cancer Study Group, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria · Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle · Alan S. Coates, International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia · Eva Ciruelos, University Hospital 12 de Octubre and SOLTI Group, Madrid · Meritxell Bellet, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, and SOLTI Group, Universitat Autònoma de Barcelona, Barcelona · Ana Lluch, Hospital Clinico Universitario de Valencia, Incliva Biomedical Research Institute, University of Valencia and SOLTI Group, Valencia · Antonia Perelló, Hospital Universitari Son Espases and SOLTI Group, Palma de Mallorca, Spain · Lorenzo Pavesi, Salvatore Maugeri Foundation and International Breast Cancer Study Group, Pavia · Marilena Visini, Ospedale Civile di Lecco and International Breast Cancer Study Group, Lecco · Carlo Tondini, Ospedale Papa Giovanni XXIII and International Brea · Pubmed 27022111
  • Marco Colleoni and Aron Goldhirsch, European Institute of Oncology and International Breast Cancer Study Group, Milan · Lorenzo Gianni, Ospedale degli Infermi and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rimini, Italy · Zhuoxin Sun, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center and Frontier Science and Technology Research Foundation · Zhuoxin Sun and Richard D. Gelber, Harvard T.F. Chan School of Public Health · Richard D. Gelber, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Per Karlsson, Institute of Selected Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, Gothenburg, Sweden · John F. Forbes, Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle Mater Hospital, Newcastle · Alan S. Coates, International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia · Beat Thürlimann, Breast Center Kantonsspital, St Gallen, and Swiss Group for Clinical Cancer Research · and Monica Castiglione, International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 26786933
2015
  • Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Ave, Boston, MA, 02215, USA. · VM Institute of Research, 6100 Av Royalmount, Montréal, QC, H4P 2R2, Canada. · AKESOgen, Inc., 3155 Northwoods Pl NW, Norcross, GA, 30071, USA. · Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Genomic and Molecular Pathology, University of Chicago, 900 E 57th St. Room 1260D, Chicago, IL, 60637, USA. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Effingerstrasse 40, 3008, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Breast Center, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Auckland City Hospital, PO Box 26498, Epsom, Auckland, 1344, New Zealand. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, Australia. · Department of Oncology, Multidisciplinary Breast Center, KULeuven (University of Leuven), University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. · Institute Georges François Leclerc, 1 Rue Professeur Marion, BP 77 980, 21079, Dijon Cedex, France. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · Program for Breast Health (Senology), European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · Institute of Oncology of Southern Switzerland (IOSI), Ospedale Italiano, Via Capelli, 6962, Viganello, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Via Ripamonti 435, 20146, Milan, Italy. · Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, 1500 E Medical Cntr Drive/SPC 5946, Ann Arbor, MI, 48109, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA. · Pubmed 26590813
  • International Breast Cancer Study Group Coordinating Center and Bern University Hospital, Inselspital, Bern, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Dana-Farber Cancer Institute and Alliance for Clinical Trials in Oncology, Boston, MA, USA. · Medical Oncology, Osp Papa Giovanni XXIII and International Breast Cancer Study Group, Bergamo, Italy. · Medical Oncology, Ospedale di Circolo and Fondazione Macchi, and International Breast Cancer Study Group, Varese, Italy. · Medical Oncology, Centro di Riferimento Oncologico, and International Breast Cancer Study Group, Aviano, Italy. · Breast Center, Kantonsspital St Gallen, Swiss Group for Clinical Cancer Research (SAKK), and International Breast Cancer Study Group, St Gallen, Switzerland. · Department of Oncology, University Hospital of Udine, University of Udine and International Breast Cancer Study Group, Udine, Italy. · Oncology Unit, Salvatore Maugeri Foundation, and International Breast Cancer Study Group, Pavia, Italy. · Surgical Oncology, Breast Services, Tata Memorial Hospital, and International Breast Cancer Study Group, Mumbai, India. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research, and International Breast Cancer Study Group, Lugano Viganello, Switzerland. · University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne and Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia, and International Breast Cancer Study Group. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, Frontier Science and Technology Research Foundation, Boston, MA, USA. · Program for Breast Health (Senology), European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group, Bern, Switzerland. · Tom Baker Cancer Centre and National Cancer Institute of Canada Clinical Trials Group, Calgary, AB, Canada. · Pubmed 26092816
  • Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mailstop CLS-11007, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia. · Australia & New Zealand Breast Cancer Trials Group (ANZBCTG), University of Newcastle, Callaghan, NSW, Australia. · The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Tom Baker Cancer Centre and NCIC Clinical Trials Group, Calgary, AB, Canada. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Pathological Department, National Institute of Oncology, Budapest, Hungary. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Division of Pathology, Salvatore Maugeri Foundation, Pavia, Italy. · Struttura Operativa Complessa di Anatomia Patologica, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy. · Kantonsspital St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland. · University of Insubria-Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Department of Pathology, Vall d'Hebron University Hospital, SOLTI Group, Barcelona, Spain. · Pathology Department, Hospital Universitario «12 de Octubre», i+12, Universidad Complutense Madrid, SOLTI Group, Madrid, Spain. · Laboratoire Anatomopathologie, Institut Bergonié, Bordeaux, France. · EORTC, Brussels, Belgium. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Program for Breast Health, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 26493064
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, USA. · Institute of Cancer Sciences, Glasgow University, Glasgow. · Southern General Hospital, Glasgow, UK. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. · Breast Center, Kantonsspital, St Gallen Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Danish Breast Cancer Cooperative Group (DBCG), Rigshospitalet, Copenhagen, Denmark. · Department of Pathology, Institut Bergonié, Bordeaux. · Department of Pathology, Val d'Aurelle Cancer Institute, Montpellier, France. · Department of Pathology, Rigshospitalet, Copenhagen, Denmark. · International Breast Cancer Study Group (IBCSG) Statistical Center. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, USA Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, USA. · International Breast Cancer Study Group, Bern, Switzerland University of Sydney, Sydney, Australia. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26387144
  • Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute · Richard D. Gelber and Meredith M. Regan, Harvard Medical School · Karen N. Price, Frontier Science and Technology Research, Boston, MA · Elizabeth Mallon, Southern General Hospital · Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom · Giuseppe Viale, European Institute of Oncology and University of Milan · Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy · Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland · Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark · Marc Debled, Institut Bergoniié, Bordeaux, France · and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Pubmed 26215945
  • International Breast Cancer Study Group, University of Sydney, Sydney, Australia. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · International Breast Cancer Study Group, Program of Breast Health (Senology), European Institute of Oncology, Milan, Italy · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Internal Medicine/Oncology, Institut Jules Bordet, Brussels, Belgium. · Breast Center, Kantonsspital St Gallen, St Gallen. · Tumor and Breast Center ZeTuP, St Gallen, Switzerland. · Pubmed 25939896
2014
  • Luzerner Kantonsspital, Lucerne, Switzerland; University of Berne, Berne, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. · National Institute of Oncology, Budapest, Hungary. · Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Leids Universitair Medisch Centrum, Leiden, Netherlands. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Baylor College of Medicine, Houston, TX, USA. · Hospital Puerta Del Mar, Cádiz, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland; Breast Center, Kantonsspital, St Gallen, Switzerland. · Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. · MD Anderson Cancer Center, Orlando, FL, USA. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · International Breast Cancer Study Group, Bern, Switzerland; University of Sydney, Sydney, Australia. · University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Stanford University School of Medicine, Stanford, CA, USA. · Pubmed 24439313
2013
  • Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy. Electronic address: · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard School of Public Health, Boston, MA, USA. · Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy. · Department of Medical and Biological Sciences, Medical Oncology, University of Udine, Udine, Italy. · Quality of Life Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Institute of Oncology, Budapest, Hungary. · Department of Oncology, Ospedale Infermi Rimini and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Rimini, Italy. · Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy. · Medical Oncology, Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Medical Oncology, Spital STS AG, Thun, Switzerland. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard School of Public Health, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · Unité de Onco-Gynécologie médicale, Departement de Médecine Hôpitaux, Universitaires de Genève, Genève, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Department of Medical Oncology, Inselspital, Bern, Switzerland. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 23453899
2012
  • International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22355052
2018
  • From the Peter MacCallum Cancer Centre, St. Vincent's Hospital, University of Melbourne, Melbourne, VIC, and Breast Cancer Trials Australia and New Zealand, University of Newcastle, Newcastle, NSW (P.A.F.), and the University of Sydney, Sydney (A.S.C.) - all in Australia · the Institute of Oncology of Southern Switzerland, Ospedale San Giovanni, Bellinzona (O.P.), Breast Cancer St. Gallen, St. Gallen (T.R.), and the International Breast Cancer Study Group Coordinating Center (R.M., M.R.-P., B.R., A.S.C.), University Hospital Inselspital (M.R.-P.), Bern - all in Switzerland · the University of Chicago Medical Center, Chicago (G.F.F.) · the University of Calgary, Calgary, AB, Canada (B.A.W.) · the Division of Medical Senology, European Institute of Oncology (M.C.), and the European Institute of Oncology and International Breast Cancer Study Group (A.G.), Milan, Ospedale Papa Giovanni XXIII, Bergamo (C.T.), Azienda Socio Sanitaria Territoriale Sette Laghi-Ospedale di Circolo and Fondazione Macchi, Varese (G.P.), Medical Oncology and Cancer Prevention, IRCCS, National Cancer Institute, Aviano (F.P., S.S.), the Department of Medicine, School of Medical Oncology, University of Udine, Udine (F.P.), Salvatore Maugeri Foundation, Pavia (L.P.), and the Hospital of Prato-Azienda Unità Sanitaria Locale Toscana Centro, Prato (A.D.L.) - all in Italy · the National Institute of Oncology, Budapest, Hungary (I.L.) · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.) · University Hospital 12 de Octubre, Madrid (E.C.), Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona (M.B.), and Instituto Valenciano de Oncologia, Valencia (M.A.C.) - all in Spain · the Susan F. Smith Center for Women's Cancers (H.J.B., E.P.W.) and the International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology (R.D.G., M.M.R.), Dana-Farber Cancer Institute, Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Frontier Science and Technology Research Foundation (R.D.G.) - all in Boston · Institut Bergonié Comprehensive Cancer Center, Université de Bordeaux, Bordeaux, France (H.R.B., M.D.) · the Angeles Clinic and Research Institute, Santa Monica, CA (S.M.) · Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond (C.E.G.) · Mayo Clinic, Rochester, MN (M.P.G., J.N.I.) · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (V.S.) · Fred Hutchinson Cancer Research Center, University of Washington, Seattle (N.E.D.) · Weston Park Hospital, Sheffield, United Kingdom (R.C.) · and the Department of Obstetrics and Gynecology, University Medical Center, Regensburg, Germany (S.B.). · Pubmed 29863451
2016
  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 3002, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Platt Street, Waratah, NSW 2298, Australia. · International Breast Cancer Study Group, Bern CH-3008, Switzerland. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Harvard Medical School, Department of Medicine, Boston, MA 02115, USA. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, Bern CH-3008, Switzerland. · Department of Medical Oncology, University Hospital of Udine, Piazzale S.M. Misericordia 15, Udine 33100, Italy. · School of Medical Oncology, The University of Udine, Udine 33100, Italy. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona 08035, Spain. · SOLTI Group, Barcelona 08008, Spain. · CRO Aviano, IRCCS, National Cancer Institute, Via F. Gallini 2, Aviano 33081, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Röda stråket 16, Gothenburg 413 45, Sweden. · Monter Cancer Center of the North Shore-LIJ Health System, 450 Lakeville Road, Lake Success, NY 11042, USA. · NRG Oncology, Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103, USA. · Department of Oncology, Breast Center CHUV, Rue du Bugnon 46, Lausanne 1011, Switzerland. · Tweed Heads Hospital, Tweed Heads, Griffith University, Gold Coast, Powell Street, Tweed Heads, NSW 2485, Australia. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA. · ECOG-ACRIN, 1818 Market Street, Suite 1100, Philadelphia, PA 19103, USA. · Frontier Science and Technology Research Foundation. · University of Sydney, Sydney, NSW 2006, Australia. · Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA 02115, USA. · Cogstate Ltd, 2/255 Bourke Street, Melbourne, VIC 3000, Australia. · Mater Hospital, 40 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Newcastle, Calvary Mater Newcastle Hospital, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), NBN Telethon Mater Institute, Locked Bag 7 HRMC, Newcastle, NSW 2298, Australia. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Ave Fl 7, New York, NY 10022, USA. · Alliance for Clinical Trials in Oncology, Chicago, IL 60637, USA. · The University of Chicago Medical Center, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637, USA. · Inselspital, Bern University Hospital, Bern CH-3010, Switzerland. · Pubmed 27092785
2011
  • National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW 1450, Australia. · Pubmed 22025143
  • NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW 1450, Australia. · Pubmed 21445568
International Breast Cancer Study Group
2018
  • National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Locked Bag 7, Camperdown, NSW, 1450, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · International Breast Cancer Study Group and Inselspital, Bern University Hospital, Bern, Switzerland. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Locked Bag 7, Camperdown, NSW, 1450, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 29329582
2017
  • James P. Morden, Lucy Kilburn, Claire Snowdon, and Judith M. Bliss, The Institute of Cancer Research · Hanna Nicholas, Cancer Research UK · R. Charles Coombes, Imperial College London, London · Gianfilippo Bertelli, Singleton Hospital, Swansea · Robert Coleman, Weston Park Hospital, Sheffield · Lesley Fallowfield, University of Sussex, Brighton · David Dodwell, St James Hospital, Leeds, United Kingdom · Isabel Alvarez, Hospital Donostia, GEICAM Spanish Breast Cancer Group, San Sebastian, Spain · Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia · Jacek Jassem, Medical University of Gdansk, Gdansk, Poland · Stephen Jones, US Oncology Research, The Woodlands, TX · Per E. Lønning, University of Bergen and Haukeland University Hospital, Bergen, Norway · Olaf Ortmann, University Medical Center Regensburg, Regensburg, Germany · Cornelis van de Velde, Leiden University Medical Centre, Leiden, the Netherlands · Jørn Andersen, Aarhus University Hospital, Aarhus, Denmark · Lucia Del Mastro, IRCCS Azienda Ospedaliera Universitaria San Martino IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy · Stig Holmberg, Sahlgrenska Universitetssjukhuset, Goteborg, Sweden · and Robert Paridaens, Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium. · Pubmed 28467729
  • NRG Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. · NRG Oncology and University of Florida Health Cancer Center at Orlando Health, Orlando, FL, USA. · NRG Oncology and Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada. · GEICAM, Instituto de Investigacion SanitariaGregorio Marañon, Universidad Complutense, Madrid, Spain. · BOOG, Dutch Breast Cancer Trialists' Group, Leids Universitair Medisch Centrum, Leiden, Netherlands. · NRG Oncology and Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · NRG Oncology and Tom Baker Cancer Centre, Calgary, Alberta, Canada. · IBCSG and National Institute of Oncology, Budapest, Hungary. · IBCSG, Bern, Switzerland and University of Sydney, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · NRG Oncology and the Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · IBCSG, Luzerner Kantonsspital, Lucerne and University of Berne, Switzerland and Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Pubmed 27663567
2015
  • Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Ave, Boston, MA, 02215, USA. · VM Institute of Research, 6100 Av Royalmount, Montréal, QC, H4P 2R2, Canada. · AKESOgen, Inc., 3155 Northwoods Pl NW, Norcross, GA, 30071, USA. · Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. · Genomic and Molecular Pathology, University of Chicago, 900 E 57th St. Room 1260D, Chicago, IL, 60637, USA. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Effingerstrasse 40, 3008, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · Breast Center, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · International Breast Cancer Study Group, Bern, Switzerland. · Auckland City Hospital, PO Box 26498, Epsom, Auckland, 1344, New Zealand. · Australia and New Zealand Breast Cancer Trials Group, Newcastle, Australia. · Department of Oncology, Multidisciplinary Breast Center, KULeuven (University of Leuven), University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. · Institute Georges François Leclerc, 1 Rue Professeur Marion, BP 77 980, 21079, Dijon Cedex, France. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group, Bern, Switzerland. · Program for Breast Health (Senology), European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. · International Breast Cancer Study Group, Bern, Switzerland. · Institute of Oncology of Southern Switzerland (IOSI), Ospedale Italiano, Via Capelli, 6962, Viganello, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Via Ripamonti 435, 20146, Milan, Italy. · Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, 1500 E Medical Cntr Drive/SPC 5946, Ann Arbor, MI, 48109, USA. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA. · Pubmed 26590813
  • Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mailstop CLS-11007, Boston, MA, 02215, USA. · Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Lugano Viganello, Switzerland. · Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia. · Australia & New Zealand Breast Cancer Trials Group (ANZBCTG), University of Newcastle, Callaghan, NSW, Australia. · The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA. · Tom Baker Cancer Centre and NCIC Clinical Trials Group, Calgary, AB, Canada. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Pathological Department, National Institute of Oncology, Budapest, Hungary. · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Division of Pathology, Salvatore Maugeri Foundation, Pavia, Italy. · Struttura Operativa Complessa di Anatomia Patologica, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy. · Kantonsspital St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland. · University of Insubria-Ospedale di Circolo and Fondazione Macchi, Varese, Italy. · Department of Pathology, Vall d'Hebron University Hospital, SOLTI Group, Barcelona, Spain. · Pathology Department, Hospital Universitario «12 de Octubre», i+12, Universidad Complutense Madrid, SOLTI Group, Madrid, Spain. · Laboratoire Anatomopathologie, Institut Bergonié, Bordeaux, France. · EORTC, Brussels, Belgium. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Program for Breast Health, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA. · University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Frontier Science and Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 26493064
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, USA. · Institute of Cancer Sciences, Glasgow University, Glasgow. · Southern General Hospital, Glasgow, UK. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. · Breast Center, Kantonsspital, St Gallen Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Danish Breast Cancer Cooperative Group (DBCG), Rigshospitalet, Copenhagen, Denmark. · Department of Pathology, Institut Bergonié, Bordeaux. · Department of Pathology, Val d'Aurelle Cancer Institute, Montpellier, France. · Department of Pathology, Rigshospitalet, Copenhagen, Denmark. · International Breast Cancer Study Group (IBCSG) Statistical Center. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, USA Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, USA. · International Breast Cancer Study Group, Bern, Switzerland University of Sydney, Sydney, Australia. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26387144
  • Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute · Richard D. Gelber and Meredith M. Regan, Harvard Medical School · Karen N. Price, Frontier Science and Technology Research, Boston, MA · Elizabeth Mallon, Southern General Hospital · Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom · Giuseppe Viale, European Institute of Oncology and University of Milan · Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy · Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland · Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark · Marc Debled, Institut Bergoniié, Bordeaux, France · and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Pubmed 26215945
2014
  • Luzerner Kantonsspital, Lucerne, Switzerland; University of Berne, Berne, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. · National Institute of Oncology, Budapest, Hungary. · Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Leids Universitair Medisch Centrum, Leiden, Netherlands. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Baylor College of Medicine, Houston, TX, USA. · Hospital Puerta Del Mar, Cádiz, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland; Breast Center, Kantonsspital, St Gallen, Switzerland. · Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. · MD Anderson Cancer Center, Orlando, FL, USA. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · International Breast Cancer Study Group, Bern, Switzerland; University of Sydney, Sydney, Australia. · University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Stanford University School of Medicine, Stanford, CA, USA. · Pubmed 24439313
2018
  • From the Peter MacCallum Cancer Centre, St. Vincent's Hospital, University of Melbourne, Melbourne, VIC, and Breast Cancer Trials Australia and New Zealand, University of Newcastle, Newcastle, NSW (P.A.F.), and the University of Sydney, Sydney (A.S.C.) - all in Australia · the Institute of Oncology of Southern Switzerland, Ospedale San Giovanni, Bellinzona (O.P.), Breast Cancer St. Gallen, St. Gallen (T.R.), and the International Breast Cancer Study Group Coordinating Center (R.M., M.R.-P., B.R., A.S.C.), University Hospital Inselspital (M.R.-P.), Bern - all in Switzerland · the University of Chicago Medical Center, Chicago (G.F.F.) · the University of Calgary, Calgary, AB, Canada (B.A.W.) · the Division of Medical Senology, European Institute of Oncology (M.C.), and the European Institute of Oncology and International Breast Cancer Study Group (A.G.), Milan, Ospedale Papa Giovanni XXIII, Bergamo (C.T.), Azienda Socio Sanitaria Territoriale Sette Laghi-Ospedale di Circolo and Fondazione Macchi, Varese (G.P.), Medical Oncology and Cancer Prevention, IRCCS, National Cancer Institute, Aviano (F.P., S.S.), the Department of Medicine, School of Medical Oncology, University of Udine, Udine (F.P.), Salvatore Maugeri Foundation, Pavia (L.P.), and the Hospital of Prato-Azienda Unità Sanitaria Locale Toscana Centro, Prato (A.D.L.) - all in Italy · the National Institute of Oncology, Budapest, Hungary (I.L.) · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.) · University Hospital 12 de Octubre, Madrid (E.C.), Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona (M.B.), and Instituto Valenciano de Oncologia, Valencia (M.A.C.) - all in Spain · the Susan F. Smith Center for Women's Cancers (H.J.B., E.P.W.) and the International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology (R.D.G., M.M.R.), Dana-Farber Cancer Institute, Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Frontier Science and Technology Research Foundation (R.D.G.) - all in Boston · Institut Bergonié Comprehensive Cancer Center, Université de Bordeaux, Bordeaux, France (H.R.B., M.D.) · the Angeles Clinic and Research Institute, Santa Monica, CA (S.M.) · Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond (C.E.G.) · Mayo Clinic, Rochester, MN (M.P.G., J.N.I.) · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (V.S.) · Fred Hutchinson Cancer Research Center, University of Washington, Seattle (N.E.D.) · Weston Park Hospital, Sheffield, United Kingdom (R.C.) · and the Department of Obstetrics and Gynecology, University Medical Center, Regensburg, Germany (S.B.). · Pubmed 29863451
2016
  • Division of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 3002, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Grattan Street, Parkville, VIC 3010, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Platt Street, Waratah, NSW 2298, Australia. · International Breast Cancer Study Group, Bern CH-3008, Switzerland. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Harvard Medical School, Department of Medicine, Boston, MA 02115, USA. · International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, Bern CH-3008, Switzerland. · Department of Medical Oncology, University Hospital of Udine, Piazzale S.M. Misericordia 15, Udine 33100, Italy. · School of Medical Oncology, The University of Udine, Udine 33100, Italy. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona 08035, Spain. · SOLTI Group, Barcelona 08008, Spain. · CRO Aviano, IRCCS, National Cancer Institute, Via F. Gallini 2, Aviano 33081, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Röda stråket 16, Gothenburg 413 45, Sweden. · Monter Cancer Center of the North Shore-LIJ Health System, 450 Lakeville Road, Lake Success, NY 11042, USA. · NRG Oncology, Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103, USA. · Department of Oncology, Breast Center CHUV, Rue du Bugnon 46, Lausanne 1011, Switzerland. · Tweed Heads Hospital, Tweed Heads, Griffith University, Gold Coast, Powell Street, Tweed Heads, NSW 2485, Australia. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA. · ECOG-ACRIN, 1818 Market Street, Suite 1100, Philadelphia, PA 19103, USA. · Frontier Science and Technology Research Foundation. · University of Sydney, Sydney, NSW 2006, Australia. · Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA 02115, USA. · Cogstate Ltd, 2/255 Bourke Street, Melbourne, VIC 3000, Australia. · Mater Hospital, 40 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Newcastle, Calvary Mater Newcastle Hospital, Australia. · Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), NBN Telethon Mater Institute, Locked Bag 7 HRMC, Newcastle, NSW 2298, Australia. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Ave Fl 7, New York, NY 10022, USA. · Alliance for Clinical Trials in Oncology, Chicago, IL 60637, USA. · The University of Chicago Medical Center, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637, USA. · Inselspital, Bern University Hospital, Bern CH-3010, Switzerland. · Pubmed 27092785
2013
  • International Breast Cancer Study Group, Division of Medical Oncology, European Institute of Oncology, Milan, Italy. · Pubmed 23917950
2012
  • IBCSG Coordinating Center, Effingerstr. 40, Bern 3008, Switzerland. · Pubmed 22531635
2011
  • International Breast Cancer Study Group, Department of Medicine, European Institute of Oncology, Milan, Italy. · Pubmed 21709140
McMaster University
2014
  • Department of Surgery, McMaster University and St Joseph's Healthcare, 50 Charlton Avenue East, G802, Hamilton, ON L8N 4A6, Canada. Electronic address: · Department of Surgery, McMaster University and St Joseph's Healthcare, 50 Charlton Avenue East, G802, Hamilton, ON L8N 4A6, Canada; Department of Surgical Oncology, Hamilton Health Sciences and Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada. · Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada. · Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada; Biostatistics Unit, St Joseph's Healthcare, Hamilton, ON, Canada. · Department of Surgery, McMaster University and St Joseph's Healthcare, 50 Charlton Avenue East, G802, Hamilton, ON L8N 4A6, Canada. · Department of Surgery, McMaster University and St Joseph's Healthcare, 50 Charlton Avenue East, G802, Hamilton, ON L8N 4A6, Canada; Department of Surgical Oncology, Hamilton Health Sciences and Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada. · Pubmed 24315382
2014
  • Department of Surgery, McMaster University, G802, St. Joseph's Healthcare 50 Charlton Avenue East, Hamilton, ON, L8N 4A6, Canada, · Pubmed 24595798
20 Other Locations Show
Yearly article counts 07598758900
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.